Pricing Log in Create free account

Lunai Bioworks Inc. (LNAI) vs NuCana PLC Sponsored ADR (NCNA)

Lunai Bioworks Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Lunai Bioworks Inc. and NuCana PLC Sponsored ADR are of similar size ($4.4M and $4.2M). NuCana PLC Sponsored ADR has the higher net margin (0.00% vs −3,761.9%) and the lower return on invested capital (−1,130.2% vs 0.00%). Across the 12 metrics below, Lunai Bioworks Inc. leads on 6 and NuCana PLC Sponsored ADR on 6.

Valuation

Metric LNAI NCNA Biotechnology median
P/E n/m n/m 8.50
P/S 24.13 n/m 9.71
P/B n/m 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.45 0.64
EV/Sales 18.71 n/m 9.21
Earnings yield (150.78%) (226,311.31%) (33.15%)
Free cash flow yield (232.47%) (170,262.15%) (25.50%)

Profitability

Metric LNAI NCNA Biotechnology median
Gross margin (3.48%) 0.00% 65.16%
Operating margin (9,184.79%) 0.00% 0.00%
Net margin (3,761.88%) 0.00% 0.00%
Free cash flow margin (5,610.24%) 0.00% 0.00%
Return on equity 23.46% (68.70%) (56.36%)
Return on assets (39.21%) (45.24%) (48.04%)
Return on invested capital 0.00% (1,130.23%) 0.00%

Growth

Metric LNAI NCNA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 98.77% 98.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNAI NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.11 4.73 4.72
Net debt to EBITDA 0.20 1.23 0.96

Dividend

Metric LNAI NCNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LNAI NCNA Biotechnology median
Market cap 4.15m 4.40m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack